Description

What is Aripan 15 mg?

Aripan 15 mg is an atypical antipsychotic tablet manufactured by Cell Laboratories (Pvt.) Ltd. Each tablet contains 15 mg of aripiprazole, and the supplied pack contains 30 tablets (3 × 10). The manufacturer’s information also identifies Aripan as an aripiprazole antipsychotic available in 10 mg, 15 mg, and 20 mg strengths.

Aripiprazole’s exact mechanism in schizophrenia and bipolar disorder is not fully understood. FDA prescribing information indicates that its clinical effects may involve partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors and antagonist activity at serotonin 5-HT2A receptors.

Aripan 15 mg Composition

• Brand: Aripan
• Generic name: Aripiprazole
• Strength: 15 mg per tablet
• Dosage form: Oral tablet
• Therapeutic class: Atypical antipsychotic
• Pack size: 30 tablets
• Pack configuration: 3 × 10 tablets
• Manufacturer: Cell Laboratories (Pvt.) Ltd.

Uses & Benefits of Aripan 15 mg

Aripan 15 mg may be prescribed for psychiatric conditions where modulation of dopamine and serotonin signalling is clinically appropriate.

FDA prescribing information for aripiprazole includes schizophrenia, acute manic or mixed episodes associated with bipolar I disorder, adjunctive treatment of major depressive disorder in adults, irritability associated with autistic disorder, and Tourette’s disorder. These FDA indications relate to aripiprazole as an active medicine; use of the Aripan brand in Pakistan should follow its locally registered product information and the treating doctor’s prescription.

Potential uses include:

• Schizophrenia: Helps reduce symptoms such as hallucinations, delusions, disorganized thinking, suspiciousness, and behavioural disturbance.
• Bipolar I disorder: Aripan 15 mg may be used for manic or mixed episodes and in selected maintenance-treatment plans.
• Mania: May help reduce excessive energy, agitation, irritability, racing thoughts, and abnormal mood elevation.
• Adjunctive treatment for major depressive disorder: Aripiprazole can be added to an antidepressant in selected adults when response to antidepressant treatment alone is inadequate.
• Irritability associated with autistic disorder: Aripiprazole has an FDA-recognized pediatric indication for irritability associated with autistic disorder, but treatment requires specialist dosing and monitoring.
• Long-term symptom control: In suitable patients, continuing prescribed antipsychotic therapy can help reduce relapse risk.

Aripan 15 mg is not a sedative or an instant cure for psychiatric illness. The goal is controlled management of symptoms as part of an individualized psychiatric treatment plan.

Who Should Use This?

Aripan 15 mg may be relevant for:

• Adults diagnosed with schizophrenia
• Adults with bipolar I disorder
• Adults experiencing manic or mixed episodes
• Adults receiving aripiprazole as adjunctive therapy for major depressive disorder
• Adolescents with specific psychiatric indications under specialist supervision
• Selected pediatric patients for indications where aripiprazole is clinically appropriate

FDA information supports aripiprazole for schizophrenia in adolescents aged 13–17 years, bipolar mania in patients aged 10–17 years, and irritability associated with autistic disorder in patients aged 6–17 years.

However, Aripan 15 mg is not automatically the correct starting dose for children or adolescents. Pediatric aripiprazole therapy commonly begins with substantially lower doses and is gradually titrated. Specialist supervision is essential.

How to Use / Dosage

Take Aripan 15 mg exactly as prescribed by the psychiatrist or physician. Do not adjust the dosage because symptoms improve or worsen without first obtaining medical advice.

For reference, FDA prescribing information for aripiprazole states that:

• For adult schizophrenia, the recommended starting and target dosage is 10 or 15 mg once daily.
• For adult bipolar I manic or mixed episodes, a recommended starting dosage is 15 mg once daily as monotherapy; when used with lithium or valproate, the dosing range may differ. The target is commonly 15 mg/day, with a maximum of 30 mg/day depending on clinical response.
• For adjunctive treatment of major depressive disorder in adults, FDA guidance starts much lower at 2–5 mg/day, with a recommended range of 2–15 mg/day. Therefore, a full Aripan 15 mg tablet is not necessarily an appropriate starting dose for depression augmentation.
• For irritability associated with autistic disorder, pediatric treatment starts at 2 mg/day and may gradually increase to 5, 10, or 15 mg/day according to response.

Aripiprazole tablets can generally be taken with or without food.

Do not stop Aripan 15 mg abruptly unless urgent medical circumstances require it and a healthcare professional instructs you to do so. Treatment changes are usually planned according to symptoms, duration of therapy, and other medicines being used.

Price in Pakistan

Price in Pakistan: PKR 750.00

The provided price of Aripan 15 mg is PKR 750.00 for 30 tablets (3 × 10 tablets).

Retail prices may vary between pharmacies, locations, stock batches, and subsequent manufacturer price revisions.

Precautions & Side Effects

Important Precautions

Before starting Aripan 15 mg, tell the prescribing doctor about diabetes, high cholesterol, cardiovascular disease, low blood pressure, seizures, swallowing problems, pregnancy, breastfeeding, liver problems, previous movement disorders, or any history of severe reactions to antipsychotic medicines.

FDA labeling identifies several important risks associated with atypical antipsychotics and aripiprazole, including hyperglycemia/diabetes, dyslipidemia, weight gain, tardive dyskinesia, neuroleptic malignant syndrome, orthostatic hypotension, seizures, and cognitive or motor impairment.

Aripiprazole can also be associated with unusual impulse-control behaviours, including uncontrollable gambling, shopping, binge eating, or sexual urges. Patients and caregivers should inform the treating doctor promptly if new or intense compulsive behaviours develop.

Aripan 15 mg and other antipsychotics are not approved for treating dementia-related psychosis in elderly patients because antipsychotic treatment in this population is associated with increased mortality.

When aripiprazole is used as an adjunct to antidepressants, patients—particularly younger patients—should also be monitored for worsening depression or emergence of suicidal thoughts or behaviour.

Possible Side Effects

Possible side effects of Aripan 15 mg can include:

• Akathisia or an uncomfortable feeling of restlessness
• Nausea or vomiting
• Constipation
• Headache
• Dizziness
• Sleepiness
• Insomnia
• Anxiety or agitation
• Tremor
• Fatigue
• Blurred vision
• Changes in appetite or body weight
• Other extrapyramidal or movement-related symptoms

FDA data identify akathisia as a commonly observed adverse reaction in adults with schizophrenia, while somnolence, tremor, and extrapyramidal symptoms are particularly important to monitor in younger patients.

Seek Urgent Medical Attention If

Urgent medical assessment is appropriate for symptoms such as high fever with severe muscle stiffness or confusion, significant involuntary movements, seizures, fainting, severe allergic reaction, marked changes in consciousness, severe hyperglycemia symptoms, or suicidal thoughts.

Patients using Aripan 15 mg should also report any severe or unexpected adverse reaction to their healthcare professional.

In Pakistan, the Drug Regulatory Authority of Pakistan (DRAP) operates the National Pharmacovigilance Centre and accepts adverse-event reports from patients, caregivers, healthcare professionals, and industry.

Monitoring During Aripan 15 mg Treatment

Patients taking Aripan 15 mg may require periodic psychiatric and physical monitoring. Depending on individual risk factors, the treating clinician may monitor symptom response, mood, movement-related adverse effects, restlessness, body weight, blood glucose, lipid levels, blood pressure, adherence, and changes in behaviour.

Children and adolescents receiving aripiprazole require particular attention to weight gain and neurological side effects. FDA prescribing information specifically recommends monitoring pediatric weight gain against expected normal growth.

Frequently Asked Questions (FAQs)

What is the price of Aripan 15 mg in Pakistan?

The listed Aripan 15 mg price in Pakistan is PKR 750.00 for 30 tablets. Retail pharmacy prices can vary.

What are the uses of Aripan 15 mg?

Aripan 15 mg contains aripiprazole and may be prescribed for schizophrenia and bipolar I disorder. Aripiprazole can also be used as adjunctive treatment for major depressive disorder and for selected pediatric psychiatric indications under specialist supervision.

Is Aripan 15 mg used for schizophrenia?

Yes. Aripan 15 mg contains aripiprazole, and 15 mg once daily is within the FDA-recommended starting and target dosage for adult schizophrenia. The actual dose must be selected by the treating psychiatrist.

Can Aripan 15 mg be used for bipolar disorder?

Yes. Aripan 15 mg may be prescribed for adults with manic or mixed episodes associated with bipolar I disorder. FDA prescribing information lists 15 mg once daily as a recommended adult starting dose for monotherapy.

Important Medical Notice

Aripan 15 mg is a prescription psychiatric medicine. It should only be used under the supervision of a qualified physician or psychiatrist.

FDA information in this description is used as an authoritative reference for aripiprazole, while DRAP information is used for Pakistan-specific medicine safety and pharmacovigilance. This should not be interpreted as a claim that every FDA indication is independently approved for this specific brand in Pakistan. Follow the locally registered product information and the prescribing doctor’s instructions.

Do not start, discontinue, split, increase, or reduce Aripan 15 mg without professional medical advice.